FUJITA MEGUMI 藤田恵

… Alternative Names

FUJITA Megumi 藤田恵

Less

Researcher Number	50509966
Other IDs
Affiliation (based on the past Project Information) *help	2016 – 2017: 武庫川女子大学, 薬学部, 助教 2014: 武庫川女子大学, 薬学部, 講師 2011: 武庫川女子大学, 薬学部, 助手
Review Section/Research Field	Principal Investigator Medical pharmacy Except Principal Investigator Medical pharmacy
Keywords	Principal Investigator 遊走 / 浸潤 / 併用効果 / バルプロ酸 / テモゾロミド / 神経膠芽腫 / がん Except Principal Investigator アポトーシス / PPARγ / 膵臓がん … More / 創薬ターゲット / プロテオミクス / 腎臓がん / 臨床薬学 Less

Combination effects of temozolomide and valproic acid on cell invasion and migration in glioblastoma cell linesPrincipal Investigator
- Principal Investigator
  
  FUJITA MEGUMI
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Research on the therapy for pancreatic cancer by PPARgamma agonists
- Principal Investigator
  
  OKAMURA Noboru
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Discovery of novel targets for the treatment of renal cell carcinoma based on tumor proteomics
- Principal Investigator
  
  OKAMURA Noboru
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University

All 2013 2012 2011 2010

All Journal Article Presentation

[Journal Article] TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2013
- Author(s)
  H. Omatsu, A. Kuwahara, M. Yamamori, M. Fujita, T. Okuno, I. Miki, T. Tamura, K. Nishiguchi, N. Okamura, T. Nakamura, T. Azuma, T. Hirano, K. Ozawa, M. Hirai.
- Journal Title
  
  Int J Med Sci.
  
  Volume: 10 Issue: 12 Pages: 1755-1760
- DOI
  10.7150/ijms.6749
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.2012
- Author(s)
  Fujita M, Tohji C, Honda Y, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N.
- Journal Title
  
  Int J Med Sci
  
  Volume: 9 Issue: 7 Pages: 555-566
- DOI
  10.7150/ijms.4455
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590225
[Journal Article] Involvement of the mevalonate pathway in anti-proliferative effect of zoledronate on renal cell carcinoma2012
- Author(s)
  Fujita M, Tohi M, Sawada K, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N
- Journal Title
  
  ACHN. Oncol Rep
  
  Volume: 27 Pages: 1371-1376
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011
- Author(s)
  Fujita M, Yagami T, Fujio M, Tohji C, Takase K, Yamamoto Y, Sawada K, Yamamori M, Okamura N
- Journal Title
  
  Cancer Lett
  
  Volume: 312 Pages: 219-227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Proteomic identification of protein targets for 15-deoxy-Δ12, 14-prostaglandin J2 in neuronal plasma membrane2011
- Author(s)
  Yamamoto Y, Takase K, Kishino J, Fujita M, Okamura N, Sakaeda T, Fujimoto M, Yagami T
- Journal Title
  
  PLoS One
  
  Volume: 6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011
- Author(s)
  Fujita M, et al
- Journal Title
  
  Cancer Lett.
  
  Volume: 312 Issue: 2 Pages: 219-227
- DOI
  10.1016/j.canlet.2011.08.010
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cell2011
- Author(s)
  Fujita M, et al
- Journal Title
  
  Oncol.Rep.
  
  Volume: 27 Pages: 1371-1376
- DOI
  10.3892/or.2012.1683
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186, KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma2010
- Author(s)
  Kuwahara A, Yamamori M, Fujita M, Okuno T, Tamura T, Kadoyama K, Okamura N, Nakamura T, Sakaeda T
- Journal Title
  
  J Exp Clin Cancer Res
  
  Volume: 29 Pages: 100-100
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 15デオキシ-デルタ12 14-プロスタグランジンJ2の細胞膜上における標的分子であるHSP70の抗体は神経細胞死を誘導する2012
- Author(s)
  山本泰弘、高馬宏美、藤田恵、山森元博、中村任、岡村昇、矢上達郎
- Organizer
  Neuroscience 2012
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-24590225
[Presentation] 腎細胞癌に対する15-デオキシ-デルタ12, 14-プロスタグランジンJ2と各種抗腫瘍剤との併用による相乗毒性2012
- Author(s)
  山本泰弘、高馬宏美、藤田恵、山森元博、中村任、岡村昇、矢上達郎
- Organizer
  第85回日本薬理学会年会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] ヒト神経膠芽腫細胞におけるテモゾロミドの効果に及ぼす抗てんかん薬の影響2012
- Author(s)
  西口裕子、藤田恵、稲彩乃、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍メカニズムの解明2012
- Author(s)
  田路千明、藤田恵、本田陽子、山本泰弘、中村任、矢上達郎、山森元博、岡村昇
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍効果2011
- Author(s)
  田路千明、藤田恵、澤田京子、山森元博、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞におけるトログリタゾンの抗腫瘍効果に対するp38 MAPK経路の役割2011
- Author(s)
  藤尾弥希、藤田恵、田路千明、澤田京子、山森元博、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 15-デオキシ-デルタ12, 14-プロスタグランジンJ2誘導神経細胞死に対する抗エノラーゼ抗体の効果2011
- Author(s)
  山本泰弘、高瀬堅吉、藤田恵、岡村昇、栄田敏之、矢上達郎
- Organizer
  第34回日本神経科学大会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] ヒト腎臓がん細胞株ACHNに対するZoledronateの抗腫瘍効果2011
- Author(s)
  土肥麻貴子、藤田恵、澤田京子、山森元博、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞におけるトログリタゾンの抗腫瘍活性の検討2010
- Author(s)
  藤田恵、田路千明、澤田京子、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第130年会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 骨髄腫細胞株IM-9に対するzoledronateの抗腫瘍効果2010
- Author(s)
  西部香、藤田恵、澤田京子、岡村昇
- Organizer
  日本薬学会第130年会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞におけるトログリタゾンの抗腫瘍活性の検討2010
- Author(s)
  藤田恵, ら
- Organizer
  日本薬学会第130年会
- Place of Presentation
  岡山
- Year and Date
  2010-03-28
- Data Source
  KAKENHI-PROJECT-21590186

1. OKAMURA Noboru (60379401)

# of Collaborated Projects: 2 results

# of Collaborated Products: 15 results
2. YAMAMORI Motohiro (10444613)

# of Collaborated Projects: 2 results

# of Collaborated Products: 11 results
3. MAE Saori

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. YAMAGUCHI Kyoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. TSUJIYA Yoshie

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 中村任

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

FUJITA MEGUMI 藤田 恵

FUJITA Megumi 藤田 恵

Research Projects

Research Products

Co-Researchers

Combination effects of temozolomide and valproic acid on cell invasion and migration in glioblastoma cell linesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research on the therapy for pancreatic cancer by PPARgamma agonists

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Discovery of novel targets for the treatment of renal cell carcinoma based on tumor proteomics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Involvement of the mevalonate pathway in anti-proliferative effect of zoledronate on renal cell carcinoma2012

Author(s)

Journal Title

Data Source

[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011

Author(s)

Journal Title

Data Source

[Journal Article] Proteomic identification of protein targets for 15-deoxy-Δ12, 14-prostaglandin J2 in neuronal plasma membrane2011

Author(s)

Journal Title

Data Source

[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cell2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma2010

Author(s)

Journal Title

Data Source

[Presentation] 15デオキシ-デルタ12 14-プロスタグランジンJ2の細胞膜上における標的分子であるHSP70の抗体は神経細胞死を誘導する2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 腎細胞癌に対する15-デオキシ-デルタ12, 14-プロスタグランジンJ2と各種抗腫瘍剤との併用による相乗毒性2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] ヒト神経膠芽腫細胞におけるテモゾロミドの効果に及ぼす抗てんかん薬の影響2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍メカニズムの解明2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍効果2011

FUJITA MEGUMI 藤田恵

FUJITA Megumi 藤田恵